Motion Sickness Drug Market Growth, Size & Forecast by 2034

Coverage: By Treatment Type (Anticholinergics, Antihistamines, Others); Distribution Channel (Retail Pharmacies, Online Pharmacies, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00022327
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 17, 2026
Motion Sickness Drug Market Growth, Size & Forecast by 2034
Report Date: April 17, 2026   |   Report Code: TIPRE00022327 Email: sales@theinsightpartners.com

2025 Market Size

US$ 1.29 Bn

Base year value

2034 Forecast

US$ 1.85 Bn

Projected by 2034

CAGR 2026-2034

4.15 %

Growth rate

Addressable Market

US$ 14.31 Bn

(2026-2034)

The global motion sickness drug market size is projected to reach US$ 1.85 billion by 2034 from US$ 1.29 billion in 2025. The market is anticipated to register a CAGR of 4.15% during the forecast period 2026-2034.

The report is segmented by Treatment Type (Anticholinergics, Antihistamines, Others). The report is segmented by Distribution Channel (Retail Pharmacies, Online Pharmacies, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Motion Sickness Drug Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Motion Sickness Drug Market Segmentation

Treatment Type

  • Anticholinergics
  • Antihistamines
  • Others

Distribution Channel

  • Retail Pharmacies
  • Online Pharmacies
  • Others

Market Assessment and Insights

  • Global market for Motion Sickness Drug was valued at US$ 1.29 Billion in 2025
  • Annual market size is expected to reach US$ 1.85 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 14.31 Billion
  • Market is anticipated to register a CAGR of 4.15% during the forecast period
  • The United States represents a key market, supported by Tourism and Travel Opportunities, The Rise in the Health Challenges Awareness, Creative Solutions in the Existing Drugs, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Development of Combination Therapies, Innovations in Drug Delivery Systems, Strategic Collaborations and Partnerships are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including GlaxoSmithKline plc, Perrigo Company plc, Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc, Myungmoon Pharm Co. Ltd, Baxter International Inc, CVS Health, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Motion Sickness Drug Market: Strategic Insights

motion-sickness-drug-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Motion Sickness Drug Market Growth Drivers

  • Tourism and Travel Opportunities: One of the key factors propelling the growth of motion sickness drugs market is the growing travel and tourism business across the globe. There is a rise in the number of people going for air travel, cruises, road trips and other forms of international traveling, resulting to very many cases of motion sickness. This is mainly because airlines, cruise lines, and transportation companies are very keen on the comfort of their clients which includes providing motion sickness management drugs. This has escalated the need for effective medicine for motion sickness disorders.
  • The Rise in the Health Challenges Awareness: With the increase in health consciousness around the world, the ailments such as motion sickness are also coming into the limelight. Almost everyone at one time has experienced motion sickness, which is basically when the eyes and ear get signals of movement while the body remains motionless. This has made certain consumers turn to the solutions that the market is providing to solve the problem, especially OTC products and prescription drugs. This transformation is due to the effects of the campaigns and due to the increased urge to self-manage simple disorders.
  • Creative Solutions in the Existing Drugs: It would be correct to say that the producers of motion sickness drugs have greatly improved over the years. There has been an improvement from the more simplistic drugs known to guarantee effectiveness at the cost of a strong tendency towards sleep. The emerging popularity of non-sedative medications, skin patches and even herbals is for the people who want something different or easier. The extended range of products has increased the volume of the motion sickness drugs market as it has been designed for different ages and health conditions.

Motion Sickness Drug Market Future Trends

  • The Enhanced Acceptability to Patients of Non-Sedating Drugs: A noteworthy development in the motion sickness drugs market is increased acceptance of non-drowsy or less drowsy medications. Older therapies such as dimenhydrinate or diphenhydramine, which are present in many over-the-counter medicines, still have a sedative effect on the patient. However, there is a growing market for additional medications and delivery methods that can relieve symptoms without the associated drowsiness especially among people whose jobs do not allow for such, drivers, students, and long-haul travelers for example.
  • Use of Natural and Herbal Remedies: There is a growing market for medicinal products based on plants and this is in accord with the growing acceptability of the products that are regarded as holistic and organic. Apart from ginger and peppermint motion sickness has some wristbands which relieve the condition through acupuncture and are in high demand. In this case, the market is offering solutions that blend traditional systems with natural ones for those who do not want to use medicines.
  • New Developments in Medicine: In personalized medicine, pharmaceutical companies pursue the goal of developing the treatment regimen according to every patient. Motion sickness is caused by different genes and sensitivities and it has its own different factors that are triggers for different peoples, hence treatment options have to be more specific. Customized drug therapies or thereby combination therapies could be developed useful in the treatment of diseases with the outmost side effects.

Motion Sickness Drug Market Opportunities

  • Development of Combination Therapies: There is an increasing complication in the understanding of motion sickness, together with the myriad of causes for the same, which has made it possible to think of combination therapies. For instance, anti: nausea agents could be combined with other medications such as anti: anxiety or anti: inflammatory drugs in a bid to enhance efficacy. Such therapies would be appropriate for individuals experiencing more than one motion sickness symptom at a time, or who have particular triggers for motion sickness.
  • Innovations in Drug Delivery Systems: Another area where the potential for advancement can be tapped is in the area of drug delivery systems that are intended to enhance the efficacy, efficiency and ease of use of the therapies for motion sickness. Patches, gels, and nasal sprays, for instance, have been invented to give patients a form of medication other than that taken by mouth. Such systems are also capable of offering localized therapy and allowing quicker onset of effect. For instance, transdermal patches enable the drug to be released at a constant rate, which is ideal for her clients who travel for long hours.
  • Strategic Collaborations and Partnerships: The market of medication against motion sickness creates possibilities for strategic alliances between pharmaceutical companies and manufacturers of wearable devices as well as research establishments. This is useful in the case where there are combinations of drug therapies and non: drug therapies incorporating devices such as motion: sensing technologies. Such collaborations might also result in extensions in regards to the existing limitations of the drugs developed for motion sickness.

Motion Sickness Drug Market Report Scope

Report Attribute Details
Market size in 2025 US$ 1.29 Billion
Market Size by 2034 US$ 1.85 Billion
Global CAGR (2026 - 2034) 4.15%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Treatment Type
  • Anticholinergics
  • Antihistamines
  • Others
By Distribution Channel
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GlaxoSmithKline plc
  • Perrigo Company plc
  • Prestige Consumer Healthcare Inc.
  • WellSpring Pharmaceutical Corporation
  • Caleb Pharmaceuticals Inc
  • Myungmoon Pharm Co. Ltd
  • Baxter International Inc
  • CVS Health

Motion Sickness Drug Market Players Density: Understanding Its Impact on Business Dynamics

The Motion Sickness Drug Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

motion-sickness-drug-market-cagr

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Motion Sickness Drug Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Motion Sickness Drug Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The Motion Sickness Drug Market is growing at a CAGR of 4.14% from 2026 to 2034

The major factors driving the Motion Sickness Drug market are:

1. Tourism and Travel Opportunities

2. The Rise in the Health Challenges Awareness

Development of Combination Therapies growth act as a opportunity for growth of the market in forecast period.

North America region dominated the Motion Sickness Drug market in 2025.

Retail Pharmacies segment, by distribution channel, dominated the market in 2025.

Players operating in the market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc, Myungmoon Pharm Co. Ltd, Baxter International Inc, CVS Health
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA